Webinar & Video:
Learn more from experts and stay on top of science. Webinars are FOR FREE, tickets are limited.
NEW Products: Mighty Match for your MSC Culture
by Dejan Husman, PhD, CEO denovoMatrix
Date: Thur, Feb, 6, 2020
3.30 PM (English) CET/MEZ
Interested in reducing or completely eliminating serum content in your media? But so far your cell performance has suffered?
Using serum-containing media limits the impact of your research on human mesenchymal stromal cells (#hMSC) and impedes the #reproducibility of your results. Find out how chemically defined coating can speed up the process.
#hMSC #Chemically defined coating #Serum-free #xeno-free #denovoMATRIX #TUDresden #Microenvironment
Register now :
10 AM (German) https://attendee.gotowebinar.com/register/1138192851064794124
3:30 PM (English) https://register.gotowebinar.com/register/6369809913644455949
presented by Dejan Husman, CEO denovoMatrix, Dresden.
Your challenge: Are you interested in reducing or completely eliminating serum content in your media? But so far your cell performance has suffered?
Using serum-containing media limits the impact of your research on human mesenchymal stromal cells (#hMSC) in non-clinical and clinical applications, and impedes the #reproducibility of your results. So you might be considering now using chemically defined coatings for your serum-free or xeno-free hMSC-Culture.
In this webinar you will learn about a new perfect coating for MSC Culture.
Chemically defined cell adhesion-promoting microenvironment offered as pre-coated cultureware, specially formulated for expansion of human mesenchymal stromal cells (hMSC) in serum-free and xeno-free media.
~Chemically defined coating
~Serum-free and xeno-free hMSC culture
~Storage at room temperature
denovoMATRIX is a TUDresden spinoff which develops and manufactures biomimetic thin layer coatings that enable the culture of a wide variety of primary, stem and established cell lines. Their vision is to recreate the microenvironment of the human body in laboratory conditions, and thereby accelerate the real-world implementation of cell therapies.